Comments on: Switch from biologic to biosimilar drug requires monitoring, patient-informed discussion

Comments on: Switch from biologic to biosimilar drug requires monitoring, patient-informed discussion https://www.benefitscanada.com/news/bencan/switch-from-biologic-to-biosimilar-drug-requires-monitoring-patient-informed-discussion/ Canada's most influential pension and benefits publication for decision-makers Mon, 17 Jun 2019 19:34:52 +0000 hourly 1 https://wordpress.org/?v=4.9.8